Bezalip SR (bezafibrate) / AbbVie, Intercept, Miravo 
Welcome,         Profile    Billing    Logout  
 0 Diseases   3 Trials   3 Trials   164 News 
4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bezalip SR (bezafibrate) / AbbVie, Intercept, Miravo
NCT06488911: To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

Enrolling by invitation
3
133
Europe, Canada, US, RoW
FDC tablet (OCA 5 mg + BZF 400 mg SR)
Intercept Pharmaceuticals
Primary Biliary Cholangitis
01/29
03/30
2022-001241-20: Study to determine if the investigational drug obeticholic acid (also known as OCA) in combination with the investigational drug bezafibrate (BZF), has an effect on Primary Biliary Cholangitis (also known as PBC). Studio per determinare se il farmaco sperimentale acido obeticolico (noto anche come OCA) in combinazione con il farmaco sperimentale bezafibrato (BZF) ha un effetto sulla colangite biliare primitiva (nota anche come PBC).

Not yet recruiting
2
60
Europe
Obeticholic Acid, Bezafibrate, [-], Tablet, Ocaliva 5mg
INTERCEPT PHARMACEUTICALS INC., Intercept Pharmaceuticals, Inc.
Primary Biliary Cholangitis Colangite biliare primitiva, Primary Biliary Cholangitis Colangite biliare primitiva, Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]
 
 
NCT05239468: Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

Active, not recruiting
2
60
US
Bezafibrate 100 mg, Bezafibrate 200 mg, Obeticholic Acid 5 mg, Obeticholic Acid placebo, Bezafibrate Placebo
Intercept Pharmaceuticals
Primary Biliary Cholangitis
11/24
02/25
NCT04594694 / 2018-002575-17: Study of OCA in Combination with BZF Evaluating Efficacy, Safety, and Tolerability in Participants with PBC

Active, not recruiting
2
72
Europe, RoW
Obeticholic acid, Bezafibrate 200 MG, OCA Placebo, Bezafibrate 200 mg Placebo, Bezafibrate 400 MG, Bezafibrate 400 mg Placebo, OCA, Bezafibrate
Intercept Pharmaceuticals
Primary Biliary Cholangitis
10/25
10/25

Download Options